This section of the GSK study register provides citations from pre-clinical research where there is a GSK author. Please note that there may be other publications that are not listed here.
To find citations, enter a key word into the Citation Text Search field and/or enter a Publication Year.
|2018||Annibaldi A, Wicky John S, Vanden Berghe T, et al. Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2. Mol Cell. 2018;69(4):566-580 e565.|
|2018||Blakemore DC, Castro L, Churcher I, et al. Organic synthesis provides opportunities to transform drug discovery. Nat Chem. 2018;10(4):383-394.|
|2018||Brown KK, Hann MM, Lakdawala AS, Santos R, Thomas PJ, Todd K. Approaches to target tractability assessment – a practical perspective. MedChemComm. 2018;9(4):606-613.|
|2018||Bueno JM, Calderon F, Chicharro J, et al. Synthesis and Structure-Activity Relationships of the Novel Antimalarials 5-Pyridinyl-4(1 H)-Pyridones. J Med Chem. 2018;61(8):3422-3435.|
|2018||Caltabiano AM, Foley JP, Striegel AM. Aqueous size-exclusion chromatography of polyelectrolytes on reversed-phase and hydrophilic interaction chromatography columns. Journal of chromatography A. 2018;1532:161-174.|
|2018||Caltabiano AM, Foley JP, Striegel AM. Organic solvent modifier and temperature effects in non-aqueous size-exclusion chromatography on reversed-phase columns. Journal of chromatography A. 2018;1531:83-103.|
|2018||Campbell IB, Macdonald SJF, Procopiou PA. Medicinal chemistry in drug discovery in big pharma: past, present and future. Drug Discov Today. 2018;23(2):219-234.|
|2018||Carroll RG, Zaslona Z, Galvan-Pena S, et al. An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation. The Journal of biological chemistry. 2018;293(15):5509-5521.|
|2018||Castellanos MM, Howell SC, Gallagher DT, Curtis JE. Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulation : Part I: Dilute protein solutions. Anal Bioanal Chem. 2018;410(8):2141-2159.|
|2018||Castellanos MM, Mattison K, Krueger S, Curtis JE. Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulation : Part II: Concentrated protein solutions. Anal Bioanal Chem. 2018;410(8):2161-2171.|
|2018||Chen H, Kankel MW, Su SC, Han SWS, Ofengeim D. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death Differ. 2018;25(4):646-660.|
|2018||Cheung M, Tangirala RS, Bethi SR, et al. Discovery of Tetralones as Potent and Selective Inhibitors of Acyl-CoA:Diacylglycerol Acyltransferase 1. ACS Med Chem Lett. 2018;9(2):103-108.|
|2018||Ching T, Himmelstein DS, Beaulieu-Jones BK, et al. Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018;15(141).|
|2018||Cortada-Garcia M, Weheliye WH, Dore V, Mazzei L, Angeli P. Computational fluid dynamic studies of mixers for highly viscous shear thinning fluids and PIV validation. Chemical Engineering Science. 2018;179:133-149.|
|2018||Cribbs A, Hookway ES, Wells G, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. The Journal of biological chemistry. 2018;293(7):2422-2437.|
|2018||Dalton SE, Dittus L, Thomas DA, et al. Selectively Targeting the Kinome-Conserved Lysine of PI3Kdelta as a General Approach to Covalent Kinase Inhibition. J Am Chem Soc. 2018;140(3):932-939.|
|2018||Deaton DN, Haffner CD, Henke BR, et al. 2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships. Bioorganic & medicinal chemistry. 2018;26(8):2107-2150|
|2018||Ding H, Douglass EF, Jr., Sonabend AM, et al. Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm. Nat Commun. 2018;9(1):1471.|
|2018||Donovan BT, Bandyopadhyay D, Duraiswami C, Nixon CJ, Townsend CY, Martens SF. Discovery and electrophysiological characterization of SKF-32802: A novel hERG agonist found through a large-scale structural similarity search. Eur J Pharmacol. 2018;818:306-327|
|2018||Edney D, Hulcoop DG, Leahy JH, et al. Development of Flexible and Scalable Routes to Two Phosphatidinylinositol-3-kinase Delta Inhibitors via a Common Intermediate Approach. Organic Process Research & Development. 2018;22(3):368-376.|
|2018||Ferdous MM, Bao Y, Vinciotti V, Liu X, Wilson P. Predicting gene expression from genome wide protein binding profiles. Neurocomputing. 2018;275:1490-1499.|
|2018||Gillis WF, Lissandrello CA, Shen J, et al. Carbon fiber on polyimide ultra-microelectrodes. J Neural Eng. 2018;15(1):016010.|
|2018||Gooris GS, Kamran M, Kros A, Moore DJ, Bouwstra JA. Interactions of dipalmitoylphosphatidylcholine with ceramide-based mixtures. Biochimica et biophysica acta. 2018;1860(6):1272-1281.|
|2018||Griffiths RJ, Kong WC, Richards SA, Burley GA, Willis MC, Talbot EPA. Oxidative beta-C-H sulfonylation of cyclic amines. Chem Sci. 2018;9(8):2295-2300.|
|2018||Hartkamp R, Moore TC, Iacovella CR, et al. Composition Dependence of Water Permeation Across Multicomponent Gel-Phase Bilayers. J Phys Chem B. 2018;122(12):3113-3123.|
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.